Background A preponderance of male fetuses in pregnancies complicated by pre-eclampsia was described over 40 years ago. Since then, however, there has been conflicting evidence in the literature, with some studies supporting a male preponderance, some demonstrating no relationship with fetal sex, and others reporting increased risk in pregnancies bearing females.
Introduction
Male fetal sex has been associated with an increased risk of multiple adverse obstetrical outcomes at delivery, including preterm delivery, premature rupture of membranes, shoulder dystocia, non-reassuring fetal heart-rate patterns, umbilical cord prolapse, true umbilical cord knot, caesarean delivery, and lower Apgar scores. 1, 2 It has recently emerged that male fetal sex is associated with an increased risk of gestational diabetes mellitus (GDM), a major medical complication of pregnancy. [3] [4] [5] The pathophysiological basis for this risk appears to be poorer maternal pancreatic beta-cell function in women who are carrying a male fetus. 3, 4 It thus emerges that the sex of the fetus may affect maternal physiology.
Like GDM, pre-eclampsia/eclampsia is another major medical complication of pregnancy that reflects abnormal maternal physiology. Interestingly, an increased risk of pre-eclampsia when carrying a male fetus was described over 40 years ago, 6 and has persisted in clinical lore in some quarters, with multiple supporting studies. 7, 8 There have been conflicting findings in the literature, however, with some studies reporting no association with fetal sex, 9, 10 and others describing a female preponderance.
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As such, the relationship between fetal sex and preeclampsia/eclampsia is still unclear. Thus, in this context, we performed a systematic review and meta-analysis of observational studies to evaluate the relationship between fetal sex and the maternal risk of pre-eclampsia/ eclampsia.
Methods

Data sources and searches
This systematic review and meta-analysis is reported in accordance with the Meta-Analysis of Observational Studies in Epidemiology guidelines, 12 and is registered with the International Prospective Register of Systematic Reviews (PROSPERO, CRD42015017114). The researchers are experienced in meta-analysis studies. [13] [14] [15] [16] We used Embase and PubMed databases to find relevant studies published between January 1950 and 4 April 2015. The following combined text and Medical Subject Heading (MeSH) terms were used: 'pregnancyinduced hypertension' and 'fetal sex'. The complete PUBMED search strategy was as follows:
) AND (Hypertension, Pregnancy-Induced [Mesh])). All potentially eligible studies were considered for review, regardless of the primary outcome or language. We also performed a manual search to include additional relevant articles, using the reference lists of key articles published in English.
Study selection
Studies were considered for inclusion if they presented original data for retrospective or prospective observational studies (cohort studies) and reported the risk of maternal pre-eclampsia/eclampsia among male and female fetuses. Given the heterogeneity of hypertensive disorders in pregnancy, we have included only studies evaluating preeclampsia/eclampsia as the outcome, excluding non-proteinuric hypertension. Our initial review included 534 studies. As diagnostic criteria for pre-eclampsia/eclampsia can differ by jurisdiction, all definitions were included in this metaanalysis. Studies were excluded if there was no control group of women without pre-eclampsia/eclampsia or if the study was restricted to specific patient populations (such as preterm delivery, multiple gestations only, or exclusively caesarean delivery). Studies were also excluded if the disease-specific fetal sex ratio could not be determined because pre-eclampsia/eclampsia was combined with preexisting or gestational hypertension.
Data extraction and quality assessment
Two independent investigators (DJ, RR) reviewed study titles and abstracts. Studies satisfying the inclusion criteria were retrieved for full-text evaluation. Studies selected for detailed analysis by these two investigators had an agreement value (j) of 96%.
Extracted data included clinical characteristics [ethnicity, study design, timing of diagnosis of pre-eclampsia/ eclampsia, length of gestation, and pre-pregnancy body mass index (BMI)] and the risk of maternal pre-eclampsia/eclampsia among male and female fetuses. Data for continuous variables were extracted as means; for categorical variables, data were extracted as absolute values. Data were extracted independently by two authors (DJ, CK) to ensure accuracy and consistency. In studies that reported data for both preterm and term pregnancies, or singleton and multiple gestation pregnancies, data for preterm and multiple gestation pregnancies were excluded if extractable. We emailed the authors of included studies with missing descriptive data and authors of excluded studies that we felt potentially may have an unpublished fetal sex ratio. We received many responses regarding descriptive data (ten authors replied stating that the data requested were not available), with one author providing additional data, but no new fetal sex ratios were obtained.
The Newcastle-Ottawa scale (NOS) was used to assess the quality of studies for this meta-analysis. 17 This scale contains four items under the selection domain, one item under the comparability domain, and three items under the outcome domain. A star scoring system is used for the semi-quantitative assessment of study quality, such that the highest quality studies are awarded one star per item, with the exception of the comparability domain, for which the maximum score is two stars for a single item. As such, the NOS score ranges from zero to nine stars. 18 
Data synthesis and analysis
An overall relative risk (RR) was calculated to determine the risk for pre-eclampsia/eclampsia among women carrying a male fetus, in comparison with those carrying a female fetus, based on absolute values obtained by each study (i.e. number of positive and negative outcomes by fetal sex). Pooled estimates of the RR risk were calculated with a random-effects model (the DerSimonian-Laird method) to adequately account for the additional uncertainty associated with study-study variability. The Cochran Q-test was used to evaluate heterogeneity between studies and a threshold P value of <0.1 was considered as statistically significant. 19 We explored heterogeneity between studies using several strategies. First, we re-ran the meta-analyses removing each study one at a time to determine whether a particular study accounted for the heterogeneity. Secondly, in light of the variability of the diagnostic protocols and criteria that have been applied for identifying pre-eclampsia/eclampsia in practice, we performed sensitivity analyses to evaluate subgroups of studies with the most stringent approaches to the diagnosis of pre-eclampsia/eclampsia, which should therefore be most likely to yield valid estimates. Thirdly, we performed meta-regression analyses including study design (population versus hospital-based), year of publication, and ethnicity (Non-Asian versus Asian populations) as covariates. Finally, we performed a series of subgroup analyses, including an analysis of studies that evaluated the NonAsian population alone, following the results of the metaregression analyses.
The possibility of publication bias was evaluated using a contour-enhanced funnel plot of effect size against the standard error for each trial. Funnel plot asymmetry was evaluated by Begg's and Egger's tests, with significant publication bias defined by P < 0.1. All statistical analyses were performed using STATA 11.0 (meta-analyses package; Stata Corporation, College Station, TX, USA).
Results
We identified 534 studies through electronic searches and three studies through manual searches (Figure 1 ). Of these, 448 were excluded based on title and abstract, leaving 89 studies for full-text evaluation. Following full-text evaluation, 67 studies were further excluded, with the majority not meeting the inclusion criteria (i.e. no control group, control group matched for fetal sex, or pre-eclampsia combined with gestational hypertension). This left a total of 22 studies on fetal sex and maternal risk of pre-eclampsia/ eclampsia.
Fetal sex and maternal risk of pre-eclampsia/ eclampsia
Twenty-two studies were included in this analysis, yielding data on 3 163 735 women. [9] [10] [11] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] Table S1 summarises the characteristics of the included studies. The studies were published between 1976 and 2014, and included mostly white European populations, with two studies in Asian populations, 11, 25 two studies in Middle Eastern populations, 9, 31 and one study in Africans. 26 Mean pre-pregnancy BMI ranged from 25.00 kg/m 2 to 29.75 kg/m 2 , and mean gestational age at delivery ranged from 36.8 to 40.0 weeks. Table S2 shows the assessment of the studies for possible bias using the Newcastle-Ottawa quality assessment scale for cohort studies (Table S2 , supplemental digital content). All studies achieved a score of at least five stars, indicating good study quality overall.
The pooled analysis of these 22 studies (n = 3 163 735) showed no association between fetal sex and maternal risk of pre-eclampsia/eclampsia (RR 1.01; 95% CI 0.97-1.05; Figure 2 ). All but four studies found no significant association between fetal sex and the risk of maternal pre-eclampsia/eclampsia. 11, 22, 24, 37 There was significant heterogeneity between estimates (I 2 = 76.2%; P < 0.001) and no evidence of publication bias on Egger regression test (P = 0.42; Figure S1) .
In an attempt to identify the sources of heterogeneity, we re-ran the meta-analysis excluding each study one at a time in order to determine whether a particular study was responsible for the high heterogeneity. Individually, no single study fully explained the heterogeneity. We then performed a sensitivity analysis excluding the three studies that did not report the diagnostic criteria used to define pre-eclampsia/eclampsia. 20, 21, 26 This analysis confirmed the absence of an association between fetal sex and maternal risk of pre-eclampsia/eclampsia (RR 1.00; 95% CI 0.95-1.05), although the heterogeneity remained (I 2 = 78.8%; P < 0.001).
We next performed meta-regression analyses including study design, year of publication, and ethnicity (Asian versus non-Asian populations), and demonstrated that ethnicity was the only covariate associated with betweenstudy variability (P = 0.006). Based on these results, we performed a subgroup analysis including only studies that evaluated the non-Asian population (n = 2 931 771), and demonstrated that male fetal sex was in fact associated with increased maternal risk of pre-eclampsia/ eclampsia (RR 1.05; 95% CI 1.03-1.06), and eliminated the heterogeneity (I 2 = 10%; P = 0.33) (Figure 3 ). Additional subgroup analyses by study design and year of publication were performed and did not eliminate heterogeneity.
Discussion
Main findings
In this meta-analysis of 22 studies involving 3 163 735 women, we demonstrate that there is no significant association between fetal sex and maternal risk of preeclampsia/eclampsia when all studies were included; however, in the non-Asian population, male fetal sex was associated with increased maternal risk of pre-eclampsia/ eclapmsia.
Strengths and limitations
A limitation of this meta-analysis is that we have pooled unadjusted estimates, so could not account for other covariates possibly associated with pre-eclampsia/eclampsia, such as maternal age and BMI. In this regard, we note that the demographic data of the study populations in most of the studies did not differ when stratified by fetal sex, suggesting that the lack of adjustment for these covariates may be less relevant to our results. Another limitation was the variability in definitions for pre-eclampsia/eclampsia among various studies; however, our results were confirmed in a subgroup analysis designed to account for this variation. In addition, we should note that our results do not address non-proteinuric hypertension in pregnancy. Lastly, the studies that did not score as well in the Newcastle-Ottawa quality assessment scale generally scored poorly on comparability, reflecting either that the study group contained Figure 2 . Meta-analysis of the association between carrying a male fetus and the risk of pre-eclampsia/eclampsia.
preterm and/or multiple gestation pregnancies or that these factors were not described in the text. We controlled for these variations by excluding data for preterm and multiple gestation pregnancies whenever extractable. Despite these limitations, the relative risk of 1.05 (95% CI 1.03-1.06) in over 2.9 million women with no significant between-study heterogeneity is strongly suggestive of the reliability of our findings.
Interpretation
It is well recognised that carrying a male fetus is associated with a higher risk of adverse obstetrical outcomes, such as preterm delivery, premature rupture of membranes, shoulder dystocia, non-reassuring fetal heart rate patterns, umbilical cord prolapse, true umbilical cord knot, caesarean delivery, and lower Apgar scores. 1, 2 In general, there exists an inherent involvement of the fetus in these outcomes that provides some plausibility for the observed association. In contrast, it has recently emerged that there is a higher risk of GDM in women who are carrying a boy, and that the underlying mechanism appears to be linked with poorer maternal pancreatic beta-cell function. [3] [4] [5] This finding suggests that fetal sex can affect maternal physiology, thereby refocusing on the longstanding question regarding the impact of fetal sex on the risk of pre-eclampsia/eclampsia.
Like GDM, pre-eclampsia is recognised as an indicator of abnormal underlying maternal physiology that extends beyond the index pregnancy, as evidenced by the increased risk of recurrent pre-eclampsia, 39, 40 and by increased lifetime risk of hypertension, cardiovascular disease, cerebrovascular events, and type-II diabetes mellitus (T2DM). [41] [42] [43] Although the exact pathogenesis of preeclampsia is not understood, it is believed to arise when 
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Risk for pre-eclampsia/eclampsia in women carrying male fetus versus female fetus Figure 3 . Meta-analysis of the association between carrying a male fetus and the risk of pre-eclampsia/eclampsia for studies on non-Asian populations.
abnormal placentation provokes a pathologic response of the maternal immune system. 44, 45 In this context, the historical association between fetal sex and the risk of preeclampsia would appear to hold biological plausibility through fetal effects on either placentation or the immune response.
A study published in 1970 initially suggested that there is a preponderance of male babies in women with preeclampsia. 6 Since then, various mechanisms have been proposed to explain this observation. One hypothesis is that male fetuses may be more likely to be viable in hypertensive pregnancies, leading to an observed male preponderance in this setting. Alternatively, it could be that the male fetus produces a factor that predisposes the mother to preeclampsia. 46 Proposed mechanisms by which a male fetus could affect the risk of pre-eclampsia include predisposing factors for abnormal implantation, 37 endothelial dysfunction in the maternal microvascular circulation, 47 fetomaternal histoincompatibility as a result of an antigen present on the Y chromosome, 6 and elevated testosterone levels. 24, 33 The fact that this association was only evident in a subgroup analysis including only the non-Asian population suggests that ethnicity may play a role in the fetomaternal interaction, which should be studied further.
There have also been many conflicting studies pertaining to fetal sex and maternal risk of pre-eclampsia/eclampsia, however. This diversity of findings is likely to have partly arisen from the inherent limitations of this literature. First, varying definitions for pre-eclampsia and eclampsia have been used in the studies comprising this literature (e.g. some studies may include gestational hypertension, whereas other studies assess all toxaemias of pregnancy). Second, the studies vary widely in their timing during gestation. Although we were not able to control for the varying definitions of pre-eclampsia/eclampsia, we excluded all studies in which gestational hypertension or pre-existing hypertension were combined with the study group. Also, our analysis had a very large sample size (>3.1 million women), allowing for the calculation of a robust estimate of the fetal sex ratio despite variations in diagnostic criteria and gestational age. In doing so, this study provides evidence of an association between male fetal sex and maternal risk of pre-eclampsia/eclampsia in non-Asian populations.
Conclusion
Accordingly, we conclude that male fetal sex is associated with maternal risk of pre-eclampsia/eclampsia in non-Asian populations.
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